Similar to other studies, our ischemic stroke cohort, when compared to non-stroke patients, also had higher markers of inflammation and coagulation such as elevated IL-6, procalcitonin, erythrocyte sedimentation rate, and D-dimer, as well as more signs of COVID-19 illness severity such as ICU admission or mechanical ventilation (22, 23). This evidence concerns the gene IL6 and stroke disorder.